Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Ji Min Kim, Euno Choi, Sun Hee Sung, Hanna Kang & Sanghui Park. (2023) Invasive urothelial carcinoma with chordoid features or abundant myxoid stroma: A reappraisal of morphologic spectrum and risk stratification based on molecular classification. Pathology - Research and Practice 251, pages 154839.
Crossref
Crossref
Francesca Sanguedolce, Ugo Giovanni Falagario, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Stefano Ascani, Simona Tortorella, Vito Mancini, Angelo Cormio, Giuseppe Carrieri & Luigi Cormio. (2023) Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer. International Journal of Molecular Sciences 24:7, pages 6610.
Crossref
Crossref
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Maria Carmela Pedicillo, Angelo Cormio, Ugo Giovanni Falagario, Giuseppe Carrieri & Luigi Cormio. (2023) HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role. International Journal of Molecular Sciences 24:4, pages 3720.
Crossref
Crossref
Anna Moshnikova, Borivoj Golijanin, Ali Amin, Joshua Doyle, Ohad Kott, Boris Gershman, Michael DuPont, Yujing Li, Xiongbin Lu, Donald M. Engelman, Oleg A. Andreev, Yana K. Reshetnyak & Dragan Golijanin. (2022) Targeting bladder urothelial carcinoma with pHLIP-ICG and inhibition of urothelial cancer cell proliferation by pHLIP-amanitin. Frontiers in Urology 2.
Crossref
Crossref
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Matteo Landriscina, Vincenza Conteduca, Ugo Giovanni Falagario, Luigi Cormio & Giuseppe Carrieri. (2022) Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation. International Journal of Molecular Sciences 23:14, pages 7844.
Crossref
Crossref
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Ugo Giovanni Falagario, Luigi Cormio & Giuseppe Carrieri. (2022) Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression. International Journal of Molecular Sciences 23:14, pages 7819.
Crossref
Crossref
Xiangpeng Zhan, Ming Jiang, Wen Deng, Xiaoqiang Liu, Luyao Chen & Bin Fu. (2022) Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database. Frontiers in Oncology 12.
Crossref
Crossref
Lin-kun Zhong, Chang-lian Xie, Shan Jiang, Xing-yan Deng, Xiao-xiong Gan, Jian-hua Feng, Wen-song Cai, Chi-zhuai Liu, Fei Shen, Jian-hang Miao & Bo Xu. (2021) Prioritizing Susceptible Genes for Thyroid Cancer Based on Gene Interaction Network. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Antonella Cormio, Gian Maria Busetto, Clara Musicco, Francesca Sanguedolce, Beppe Calò, Marco Chirico, Ugo Giovanni Falagario, Giuseppe Carrieri, Claudia Piccoli & Luigi Cormio. (2021) Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer. Diagnostics 11:8, pages 1500.
Crossref
Crossref
Francesca Sanguedolce, Beppe Calò, Marco Chirico, Ugo Falagario, Gian Maria Busetto, Magda Zanelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Giuseppe Carrieri & Luigi Cormio. (2021) Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern. Journal of Pathology and Translational Medicine 55:4, pages 239-246.
Crossref
Crossref
Francesca Sanguedolce, Beppe Calò, Vito Mancini, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Stefano Ascani, Giuseppe Carrieri & Luigi Cormio. (2021) Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications. Oncology 99:6, pages 345-358.
Crossref
Crossref
Amira Awadalla, H Abol-Enein, Mahmoud M. Gabr, Eman T. Hamam & Ahmed A. Shokeir. (2020) Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells. Urologic Oncology: Seminars and Original Investigations 38:4, pages 278-285.
Crossref
Crossref
Zihao Chen, Guojun Liu, Aslam Hossain, Irina G. Danilova, Mikhail A. Bolkov, Guoqing Liu, Irina A. Tuzankina & Wanlong Tan. (2019) A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Hereditas 156:1.
Crossref
Crossref
B. Calò, F. Sanguedolce, F. Fortunato, G. Stallone, N. d’Altilia, M. Chirico, U. Falagario, Vito Mancini, G. Carrieri & L. Cormio. (2019) The impact of age on intravesical instillation of Bacille Calmette–Guerin treatment in patients with high-grade T1 bladder cancer. Medicine 98:31, pages e16223.
Crossref
Crossref
Francesca Sanguedolce, Antonella Cormio, Paolo Massenio, Maria C. Pedicillo, Simona Cagiano, Francesca Fortunato, Beppe Calò, Giuseppe Di Fino, Giuseppe Carrieri, Pantaleo Bufo & Luigi Cormio. (2018) Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer. Journal of Cancer Research and Clinical Oncology 144:4, pages 637-644.
Crossref
Crossref
Luigi Cormio, Vito Mancini, Beppe Calò, Oscar Selvaggio, Teobaldo Mazzilli, Francesca Sanguedolce & Giuseppe Carrieri. (2017) Asymptomatic solitary bladder plasmocytoma. Medicine 96:50, pages e9347.
Crossref
Crossref
Eman N. Khorshid, Mervat M.F. El Deftar & Ghada S. Osman. (2017) Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer. Egyptian Journal of Pathology 37:2, pages 352-359.
Crossref
Crossref
Chiara Nicolazzo, Gian Maria Busetto, Francesco Del Giudice, Isabella Sperduti, Diana Giannarelli, Angela Gradilone, Paola Gazzaniga, Ettore de Berardinis & Cristina Raimondi. (2017) The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC). Journal of Cancer Research and Clinical Oncology 143:10, pages 1971-1976.
Crossref
Crossref
Gian Maria Busetto, Matteo Ferro, Francesco Del Giudice, Gabriele Antonini, Benjamin I. Chung, Isabella Sperduti, Diana Giannarelli, Giuseppe Lucarelli, Marco Borghesi, Gennaro Musi, Ottavio de Cobelli & Ettore De Berardinis. (2017) The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non–muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer 15:4, pages e661-e666.
Crossref
Crossref
Yu Yang, Jia-Xiang Guo, Zhi-Qiang Shao & Jiang-Ping Gao. (2017) Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/AKT signaling pathway: An experimental study. Asian Pacific Journal of Tropical Medicine 10:5, pages 515-519.
Crossref
Crossref
Luigi Cormio, Francesca Sanguedolce, Antonella Cormio, Paolo Massenio, Maria Carmela Pedicillo, Simona Cagiano, Giuseppe Calò, Vincenzo Pagliarulo, Giuseppe Carrieri & Pantaleo Bufo. (2017) Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer. Oncotarget 8:15, pages 25433-25441.
Crossref
Crossref
Theodoros Tokas, Margaritis Avgeris, Christos Alamanis, Andreas Scorilas, Konstantinos G. Stravodimos & Constantinos A. Constantinides. (2016) Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis. Journal of Cancer Research and Clinical Oncology 143:3, pages 521-532.
Crossref
Crossref
R. Pinto-Leite, R. Arantes-Rodrigues, Nuno Sousa, P. A. Oliveira & L. Santos. (2016) mTOR inhibitors in urinary bladder cancer. Tumor Biology 37:9, pages 11541-11551.
Crossref
Crossref
Dhanya Sooraj, Dakang Xu, Jason E. Cain, Daniel P. Gold & Bryan R.G. Williams. (2016) Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat. Molecular Cancer Therapeutics 15:7, pages 1726-1739.
Crossref
Crossref
Ying-Li Lin, Yan-Ling Wang, Xing-Li Fu, Wen-Ping Li, Yu-Hao Wang & Jian-Guo Ma. (2016) Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer. Oncotarget 7:19, pages 28384-28392.
Crossref
Crossref
T. Kekeeva, A. Tanas, A. Kanygina, D. Alexeev, A. Shikeeva, L. Zavalishina, Y. Andreeva, G.A. Frank & D. Zaletaev. (2016) Novel fusion transcripts in bladder cancer identified by RNA-seq. Cancer Letters 374:2, pages 224-228.
Crossref
Crossref